[1] Sung H,Ferlay J,Siegel RL,et al. Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71:209-249. [2] Borrelli C, Roberts M, Eletto D, et al. In vivo interaction screening reveals liver-derived constraints to metastasis[J]. Nature,2024,632:411-418. doi: 10.1038/s41586-024-07715-3. [3] Padilla J, Osman NM, Bissig-Choisat B, et al. Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model[J]. J Hepatol,2024,80:282-292. doi: 10.1016/j.jhep.2023.10.018. [4] Shankara Narayanan JS, Hayashi T, Erdem S, et al. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model[J]. J Immunother Cancer,2023, 11:e006133. doi: 10.1136/jitc-2022-006133. [5] 李屿堃,吉登波,顾晋. 双荧光标签LS174T细胞及小鼠多部位肿瘤模型的构建[J]. 中华实验外科杂志,2024,41:1329-1332. doi:10.3760/cma.j.cn421213-20231012-00233. [6] Ji S, Feng L, Fu Z,et al. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology[J]. Sci Transl Med, 2023, 15:eadg3358. doi: 10.1126/scitranslmed.adg3358. [7] 卞晓翠,王晓婉,杨振丽,等. 联合使用聚合酶链式反应和培养法可以提高培养细胞支原体的检出率[J]. 医学研究杂志,2018,47:28-34. doi:10.11969/j.issn.1673-548X.2018.06.009. [8] 潘蕊,喻锟,张海亮,等. 不同方法建立小鼠肝癌原位移植瘤模型差异性的探讨[J]. 中国实验动物学报,2024,32:329-336. doi:10.3969/j.issn.1005-4847.2024.03.006. [9] Xue R, Zhang Q, Cao Q, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity[J]. Nature, 2022, 612:141-147. doi: 10.1038/s41586-022-05400-x. [10] He L, Tian DA, Li PY, et al. Mouse models of liver cancer: progress and recommendations[J]. Oncotarget, 2015, 6:23306-22. doi: 10.18632/oncotarget.4202. |